Predictors of high‐risk angiographic findings in patients with non‐ST‐segment elevation acute coronary syndrome
- 13 November 2013
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 83 (5), 677-683
- https://doi.org/10.1002/ccd.25081
Abstract
Background Current risk assessment of patients with non‐ST‐elevation acute coronary syndrome (NSTE‐ACS) may fail to identify some patients with severe coronary artery disease (CAD). We aimed to identify predictors of the angiographic extent and severity of CAD in patients with NSTE‐ACS undergoing early angiography and to evaluate its impact on prognosis. Methods We evaluated 923 patients with NSTE‐ACS who underwent coronary angiography. High‐risk coronary anatomy (HRCA) was defined as left main disease > 50%, proximal LAD lesion > 70%, or 2‐ to 3‐vessel disease involving the LAD. Clinical characteristics, in‐hospital, and 30‐day outcome and 1‐year mortality were compared between the high‐risk (N = 370) and the low‐risk groups (N = 553). Results Proportion of patients with elevated cardiac biomarkers was similar in both groups. The presence of peripheral vascular disease (OR = 1.88, 95% confidence interval [CI] = 1.62–5.80, P < 0.001) and a GRACE score of >140 (OR = 1.88, 95% CI = 1.29–2.75, P < 0.001) were the strongest predictors of HRCA. Patients with HRCA were prone to more complications during hospitalization and at 30 days (11.9% vs. 6%, P < 0.01) and increased 1‐year mortality (6.7% vs. 0.9%, P < 0.001). HRCA was the strongest predictor for 30‐day MACCE (OR = 2.32, 95% CI = 1.42–3.79, P < 0.001). HRCA (OR = 8.36, 95% CI = 1.01–69.4, P = 0.049; OR = 3.64, 95% CI = 1.2–11.07, P = 0.02) and GRACE score of >140 (OR = 6.86, 95% CI = 1.68–27.9, P = 0.007; OR = 4.84, 95% CI = 1.74–13.5, P = 0.002) were significant predictors of 30‐day and 1‐year mortality, respectively. Conclusions HRCA is predicted by clinical parameters and was not associated with elevated cardiac biomarkers. These patients fared worse when compared with those with low‐risk anatomy. We suggest that HRCA predictors should be included in the risk stratification of patients with NSTE‐ACS.Keywords
This publication has 17 references indexed in Scilit:
- Contemporary use and outcome of percutaneous coronary interventions in patients with acute coronary syndromes: insights from the 2010 ACSIS and ACSIS-PCI surveysEuroIntervention, 2012
- Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patientsHeart, 2012
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)European Heart Journal, 2011
- 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)Circulation, 2011
- The Year in Non–ST-Segment Elevation Acute Coronary SyndromeJournal of the American College of Cardiology, 2009
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007
- Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndromeAmerican Heart Journal, 2007
- Predictors of Hospital Mortality in the Global Registry of Acute Coronary EventsArchives of Internal Medicine, 2003
- The TIMI Risk Score for Unstable Angina/Non–ST Elevation MIJAMA, 2000
- Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment ElevationCirculation, 2000